Short Interest Worth Mentioning: Carbylan Therapeutics Incorporated (NASDAQ:CBYL) Has Increase in Shorts

November 29, 2016 - By kentuckypostne   ·   0 Comments

Short Interest Worth Mentioning: Carbylan Therapeutics Incorporated (NASDAQ:CBYL) Has Increase in Shorts

The stock of Carbylan Therapeutics Incorporated (NASDAQ:CBYL) registered an increase of 11.65% in short interest. CBYL’s total short interest was 269,300 shares in November as published by FINRA. Its up 11.65% from 241,200 shares, reported previously. With 233,900 shares average volume, it will take short sellers 1 days to cover their CBYL’s short positions. The short interest to Carbylan Therapeutics Incorporated’s float is 2.05%. The stock increased 1.09% or $0.11 during the last trading session, hitting $10.21. Kalvista Pharmaceuticals Inc (NASDAQ:KALV) has declined 0.10% since April 26, 2016 and is downtrending. It has underperformed by 5.36% the S&P500.

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The company has a market cap of $23.16 million. The Firm is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. It currently has negative earnings. The Firm has developed a portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema (DME).

More notable recent Kalvista Pharmaceuticals Inc (NASDAQ:KALV) news were published by: Nasdaq.com which released: “KalVista Pharmaceuticals Announces Closing of Merger with Carbylan Therapeutics” on November 22, 2016, also Streetinsider.com with their article: “Form 3 KalVista Pharmaceuticals For: Nov 21 Filed by: Crockett Thomas Andrew” published on November 29, 2016, Quotes.Wsj.com published: “News KalVista Pharmaceuticals Inc.KALV” on October 05, 2016. More interesting news about Kalvista Pharmaceuticals Inc (NASDAQ:KALV) were released by: Globenewswire.com and their article: “Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share …” published on June 15, 2016 as well as Globenewswire.com‘s news article titled: “Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss …” with publication date: June 22, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By kentuckypostne


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>